Idt Australia logo
IDT
Pharmaceuticals, Biotechnology & Life Sciences

IDT Australia

Short interest
0.11%
+0.10 pp 30d
as of 21 May 2026
Reported shorts
449.6K
Shares on issue
427.426M

IDT Australia (IDT) financials

Results, ratios and statements

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency

Revenue
$20.4Mvs $19.2M (FY25)
Yahoo Finance, as at 14 Oct 2026
NPAT
−$2.7Mvs −$8.1M (FY25)
Yahoo Finance, as at 14 Oct 2026
EPS (diluted)
−$0.007vs −$0.019 (FY25)
Yahoo Finance, as at 14 Oct 2026
Rev YoY
+5.9%FY
EPS YoY
n/aTTM

Summary of FY26 Full Year Results, 20 Aug 2026

IDT Australia reported FY26 total revenue of $20.4 million (up 3.1% from FY25) and a net loss of $2.7 million, a 66.3% improvement on the prior year's loss. EBITDA improved 85% to -$0.9 million. No dividend was declared. The company expects positive EBITDA in FY27 and targets $50 million revenue by FY29.

Automated summary of the filing; the filing itself is the record.

Key ratios

Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 14 Oct 2026

Gross margin
78.2%
Operating margin
−8.1%
Net margin
−13.3%
FCF margin
−1.2%
ROE
−13.3%
ROA
−7.6%
FCF conversion
n/a
Net debt (excl. leases)
$8.3M
Net debt / EBITDA
n/a
Current ratio
2.3×
Interest cover
−1.3×
Cash dividends paid / net profit
n/a
Market cap
$17.1M
P/E
n/a
P/B
0.9×

Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 14 Oct 2026.

Financial statements

Figures in AUD, the reporting currency; Yahoo Finance unless marked

IDT income, newest period first, figures in AUD
Line itemFY26FY25FY24FY23
Revenue$20.4M$19.2M$13.2M$6.9M
Gross profit$15.9M$13.1M$10.4M$4.8M
Operating income−$1.6M−$7.9M−$6.9M−$9.9M
EBITDA−$561.0K−$6.4M−$5.0M−$8.8M
EBIT−$1.5M−$7.3M−$6.0M−$9.9M
Interest expense$1.3M$759.0K$119.0Kn/a
Pretax income−$2.7M−$8.1M−$6.1M−$9.8M
Tax$0$0−$662.0K−$1.3M
NPAT−$2.7M−$8.1M−$5.4M−$8.5M
Net interest income−$1.1M−$663.0K−$17.0Kn/a
EPS basic−$0.007−$0.019−$0.015−$0.034
EPS diluted−$0.007−$0.019−$0.015−$0.034
Shares427.3M429.7M351.5M312.7M